Lets see what happens - the PDS on the MIS is out - the tax benefit is still there - the return - as best I can tell the demand is growing for the traditional uses as other sources of supply decline - the pharma side is promising - mgt issues can be sorted - the NTA is much higher than the current SP
Oh and to satisfy Tuna IMO and DYOR